Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 11:12:697549.
doi: 10.3389/fgene.2021.697549. eCollection 2021.

Evidence That the Etiology of Congenital Hypopituitarism Has a Major Genetic Component but Is Infrequently Monogenic

Affiliations

Evidence That the Etiology of Congenital Hypopituitarism Has a Major Genetic Component but Is Infrequently Monogenic

Youn Hee Jee et al. Front Genet. .

Abstract

Purpose: Congenital hypopituitarism usually occurs sporadically. In most patients, the etiology remains unknown.

Methods: We studied 13 children with sporadic congenital hypopituitarism. Children with non-endocrine, non-familial idiopathic short stature (NFSS) (n = 19) served as a control group. Exome sequencing was performed in probands and both unaffected parents. A burden testing approach was used to compare the number of candidate variants in the two groups.

Results: First, we assessed the frequency of rare, predicted-pathogenic variants in 42 genes previously reported to be associated with pituitary gland development. The average number of variants per individual was greater in probands with congenital hypopituitarism than those with NFSS (1.1 vs. 0.21, mean variants/proband, P = 0.03). The number of probands with at least 1 variant in a pituitary-associated gene was greater in congenital hypopituitarism than in NFSS (62% vs. 21%, P = 0.03). Second, we assessed the frequency of rare, predicted-pathogenic variants in the exome (to capture undiscovered causes) that were inherited in a fashion that could explain the sporadic occurrence of the proband's condition with a monogenic etiology (de novo mutation, autosomal recessive, or X-linked recessive) with complete penetrance. There were fewer monogenic candidates in the probands with congenital hypopituitarism than those with NFSS (1.3 vs. 2.5 candidate variants/proband, P = 0.024). We did not find any candidate variants (0 of 13 probands) in genes previously reported to explain the phenotype in congenital hypopituitarism, unlike NFSS (8 of 19 probands, P = 0.01).

Conclusion: Our findings provide evidence that the etiology of sporadic congenital hypopituitarism has a major genetic component but may be infrequently monogenic with full penetrance, suggesting a more complex etiology.

Keywords: combined pituitary hormone deficiencies; congenital hypopituitarism; digenic; ectopic posterior pituitary gland; monogenic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer MD declared a past co-authorship with one of the authors JB to the handling editor.

Figures

FIGURE 1
FIGURE 1
Rare, predicted-pathogenic variants in subjects with congenital hypopituitarism and non-familial short stature. (A) Mean number of rare, predicted-pathogenic variants per proband in 42 genes associated with pituitary development. (B) Percent of probands with at least 1 variant in any of 42 pituitary-associated genes. (C) Mean number of monogenic candidates for the condition (hypopituitarism or non-familial short stature) per proband. Square indicates mean. Error bar shows 95% confidence interval. HP, congenital hypopituitarism; NFSS, non-familial short stature.

References

    1. Adams D. R., Sincan M., Fajardo K. F., Mullikin J. C., Pierson T. M., Toro C., et al. (2012). Analysis of DNA sequence variants detected by high-throughput sequencing. Hum. Mutat. 33 599–608. 10.1002/humu.22035 - DOI - PMC - PubMed
    1. Adzhubei I. A., Schmidt S., Peshkin L., Ramensky V. E., Gerasimova A., Bork P., et al. (2010). A method and server for predicting damaging missense mutations. Nat. Methods 7 248–249. 10.1038/nmeth0410-248 - DOI - PMC - PubMed
    1. Alatzoglou K., Kelberman D., Cowell C. T., Palmer R., Arnhold I. J. P., Melo M. E., et al. (2011). Increased transactivation associated with SOX3 polyalanine tract deletion in a patient with hypopituitarism. J. Clin. Endocrinol. Metab. 96 E685–E690. - PubMed
    1. Babu D., Fanelli A., Mellone S., Muniswamy R., Wasniewska M., Prodam F., et al. (2019). Novel GLI2 mutations identified in patients with combined pituitary hormone deficiency (CPHD): evidence for a pathogenic effect by functional characterization. Clin. Endocrinol. (Oxf) 90 449–456. - PubMed
    1. Bancalari R. E., Gregory L. C., McCabe M. J., Dattani M. T. (2012). Pituitary gland development: an update. Endocr. Dev. 23 1–15. 10.1159/000341733 - DOI - PubMed